| 1 |
23721189 | Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy. | 2013 Nov |
1 |
| 2 |
19837722 | Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole. | 2010 Jan |
3 |
| 3 |
16430719 | Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. | 2006 Feb |
1 |
| 4 |
16838393 | Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. | 2006 Oct |
1 |
| 5 |
11641425 | Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) scavenging. | 2001 Nov |
1 |
| 6 |
3139552 | Methimazole blocks Graves' IgG but not interferon-gamma HLA-DR expression by thyroid cells. | 1988 Jul |
1 |